Veerapol Kukongviriyapan Selected Research

Protein Hydrolysates

3/2018	Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model.
2/2018	Rice bran protein hydrolysates reduce arterial stiffening, vascular remodeling and oxidative stress in rats fed a high-carbohydrate and high-fat diet.
8/2015	Rice Bran Protein Hydrolysates Improve Insulin Resistance and Decrease Pro-inflammatory Cytokine Gene Expression in Rats Fed a High Carbohydrate-High Fat Diet.
7/2015	Peptides-Derived from Thai Rice Bran Improves Endothelial Function in 2K-1C Renovascular Hypertensive Rats.
2/2015	Rice bran protein hydrolysates prevented interleukin-6- and high glucose-induced insulin resistance in HepG2 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Veerapol Kukongviriyapan Research Topics

Disease

37	Cholangiocarcinoma 07/2022 - 12/2007
25	Neoplasms (Cancer) 06/2022 - 04/2009
21	Hypertension (High Blood Pressure) 01/2021 - 08/2009
8	Inflammation (Inflammations) 01/2020 - 04/2009
7	Vascular Remodeling 10/2018 - 01/2014
6	Thalassemia 07/2019 - 01/2007
5	Insulin Resistance 03/2018 - 01/2014
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2018 - 01/2014
4	Iron Overload 07/2019 - 01/2008
4	Bile Duct Neoplasms (Bile Duct Cancer) 06/2017 - 08/2010
4	beta-Thalassemia (Cooley's Anemia) 10/2012 - 01/2007
3	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
3	Fibrosis (Cirrhosis) 10/2018 - 11/2015
3	Renovascular Hypertension (Goldblatt Syndrome) 03/2018 - 07/2015
3	Carcinogenesis 11/2017 - 04/2009
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2018 - 11/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 10/2014
2	Body Weight (Weight, Body) 01/2014 - 04/2012
1	Acute Promyelocytic Leukemia 06/2022
1	Necrosis 10/2018

Drug/Important Bio-Agent (IBA)

14	AntioxidantsIBA 01/2020 - 04/2009
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2007
10	NG-Nitroarginine Methyl Ester (L-NAME)IBA 03/2020 - 05/2011
10	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 01/2007
7	Antihypertensive Agents (Antihypertensives)IBA 03/2020 - 01/2014
6	CurcuminIBA 01/2021 - 08/2010
6	EnzymesIBA 05/2018 - 04/2009
5	Glutathione (Reduced Glutathione)IBA 07/2019 - 01/2007
5	quinone (benzoquinone)IBA 01/2019 - 04/2009
5	NAD (NADH)IBA 01/2019 - 04/2009
5	Protein Hydrolysates FDA Link 03/2018 - 02/2015
5	CarbohydratesIBA 02/2018 - 01/2014
5	arginine methyl esterIBA 07/2017 - 05/2011
5	tetrahydrocurcuminIBA 12/2016 - 05/2011
4	Cisplatin (Platino)FDA LinkGeneric 06/2022 - 08/2018
4	CadmiumIBA 01/2021 - 02/2011
4	Drinking WaterIBA 03/2020 - 04/2012
4	CytokinesIBA 01/2019 - 12/2007
4	Captopril (Capoten)FDA LinkGeneric 10/2018 - 02/2016
4	Oxidoreductases (Dehydrogenase)IBA 03/2018 - 01/2014
4	asiatic acidIBA 10/2017 - 01/2014
4	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2016 - 04/2009
4	Pharmaceutical PreparationsIBA 08/2016 - 12/2009
4	Hemoglobin EIBA 11/2014 - 01/2008
3	Gemcitabine FDA Link 05/2022 - 05/2010
3	cucurbitacin BIBA 01/2021 - 01/2019
3	Transcription Factors (Transcription Factor)IBA 05/2018 - 06/2015
3	Oxidants (Oxidizing Agents)IBA 05/2018 - 01/2008
3	LipidsIBA 03/2018 - 01/2014
3	phenethyl isothiocyanate (PEITC)IBA 01/2018 - 11/2013
3	IronIBA 12/2016 - 01/2007
3	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2016 - 09/2010
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2021 - 01/2019
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2021 - 01/2019
2	MetalsIBA 01/2021 - 09/2010
2	Metformin (Glucophage)FDA LinkGeneric 01/2019 - 08/2018
2	HesperidinIBA 10/2018 - 01/2018
2	CollagenIBA 10/2018 - 11/2015
2	Glucose (Dextrose)FDA LinkGeneric 03/2018 - 02/2015
2	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2017 - 06/2015
2	LuteolinIBA 09/2016 - 01/2014
2	Superoxides (Superoxide)IBA 02/2016 - 11/2013
2	Malondialdehyde (Propanedial)IBA 02/2016 - 11/2014
2	Messenger RNA (mRNA)IBA 01/2016 - 01/2012
2	QuercetinIBA 06/2014 - 10/2012
2	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 03/2014 - 09/2010
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 03/2014 - 09/2010
2	Vasodilator Agents (Vasodilators)IBA 01/2014 - 10/2012
2	Interleukin-1beta (Interleukin 1 beta)IBA 04/2009 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 12/2007
2	Interferon-gamma (Interferon, gamma)IBA 04/2009 - 12/2007
1	momordinIBA 07/2022
1	ErbB Receptors (EGF Receptor)IBA 07/2022
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 06/2022
1	licochalcone AIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	derrischalconeIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Rice Bran OilIBA 01/2020
1	Phenformin (Fenformin)IBA 01/2020
1	Lisinopril (Prinivil)FDA LinkGeneric 01/2020
1	Pamidronate (Aredia)FDA LinkGeneric 11/2019
1	Glutamate-Cysteine LigaseIBA 07/2019
1	Oligonucleotide ProbesIBA 07/2019
1	Nuclear Proteins (Protein, Nuclear)IBA 07/2019
1	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 03/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	AMP-Activated Protein KinasesIBA 01/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019
1	myricetinIBA 01/2019
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2019
1	CoumarinsIBA 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 10/2018

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 02/2021 - 01/2012
4	Therapeutics 01/2021 - 09/2010
2	Chemoprevention 01/2020 - 08/2010
2	Surgical Instruments (Clip) 03/2018 - 07/2015
2	Blood Transfusion (Blood Transfusions) 01/2008 - 01/2007
1	Palliative Care (Palliative Therapy) 01/2021